Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: A multicenter study

Journal of Chemotherapy

Volumn 14, Issue 3, 2002, Pages 246-252

  Tortorano, Anna Maria ^a   Dannaoui, E ^a   Meletiadis, J ^a   Mallie, M ^a   Viviani, M A ^a   Piens, M A ^a   Rigoni, A L ^a   Bastide, J M ^a   Grillot, R ^a   Lebeau, B ^a   Burnod, J ^a   Nolard, N ^a   Symoens, F ^a   Goens, K ^a   Heinermann, S ^a   Bertout, S ^a   Castel, D ^a   Renaud, F ^a   De Meeus T ^a   Perraud, M ^a   Monier, M F ^a   Chapuis, F ^a   Cogliati, M ^a   Barton, R ^a   Evans, E G V ^a   Ashbee, H R ^a   Hopwood, V ^a   Meis, J F ^a   Voss, A ^a   Verweij, P E ^a   Donnelly, J P ^a   Rath, P M ^a   Ansorg, R ^a   more..

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Amphotericin B; Aspergillus fumigatus; Fungicidal activity; Fungistatic activity; Itraconazole; Posaconazole; Terbinafine; Voriconazole

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; POSACONAZOLE; TERBINAFINE; VORICONAZOLE; ANTIFUNGAL AGENT; NAPHTHALENE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DILUTION; FUNGICIDAL ACTIVITY; FUNGUS CULTURE; IN VITRO STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; CLINICAL TRIAL; CULTURE MEDIUM; DRUG EFFECT; FRANCE; HUMAN; LABORATORY; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; OBSERVER VARIATION; STANDARD;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CULTURE MEDIA; FRANCE; HUMANS; ITRACONAZOLE; LABORATORIES; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; OBSERVER VARIATION; PYRIMIDINES; TRIAZOLES;

EID: 0035986422     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.3.246     Document Type: Article

References (26)

1. Aspergillus fumigatus and aspergillosis
2. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis
3. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
4. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus
5. Potential use of terbinafine in the treatment of aspergillosis
6. In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B
7. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
8. Correlation between in vitro susceptibility testing to itraconazole and in vivo outcome of Aspergíllus fumigatus infection
9. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species
10. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents
11. Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods
12. Evaluation of different in vitro procedures for testing amphotericin B and itraconazole susceptibility of Aspergillus fumigatus
13. Susceptibility testing of pathogenic fungi with itraconazole: A process analysis of test variables
14. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation
15. Itraconazole resistance in Aspergillus fumigatus
16. Do in vitro susceptibility data predict the microbiological response to amphotericin B? Results of a prospective study of patients with Candida fungemia
17. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B
18. In vitro susceptility and synergy studies of Aspergillus species to conventional and new agents
19. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi
20. Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole
21. Comparison of the minimum fungicidal concentration of amphotericin B determined in filamentous fungi by macrodilution and microdilution methods
22. Antifungal drug resistance in Aspergillus
23. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
24. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592)
25. Organism-dependent fungicidal activities of azoles